G3 Therapeutics (G3T) is a biotechnology company that focuses on the development of therapeutics. It combines deep phenotyping data, panomic molecular profiling, and AI tools to identify and validate potential drug targets. The company is engaged in the development of drug candidates for nonalcoholic steatohepatitis (NASH) and cardiovascular disease.